Literature DB >> 24028067

Identification of a possible secondary picrotoxin-binding site on the GABA(A) receptor.

Timothy S Carpenter1, Edmond Y Lau, Felice C Lightstone.   

Abstract

The type A GABA receptors (GABARs) are ligand-gated ion channels (LGICs) found in the brain and are the major inhibitory neurotransmitter receptors. Upon binding of an agonist, the GABAR opens and increases the intraneuronal concentration of chloride ions, thus hyperpolarizing the cell and inhibiting the transmission of the nerve action potential. GABARs also contain many other modulatory binding pockets that differ from the agonist-binding site. The composition of the GABAR subunits can alter the properties of these modulatory sites. Picrotoxin is a noncompetitive antagonist for LGICs, and by inhibiting GABAR, picrotoxin can cause overstimulation and induce convulsions. We use addition of picrotoxin to probe the characteristics and possible mechanism of an additional modulatory pocket located at the interface between the ligand-binding domain and the transmembrane domain of the GABAR. Picrotoxin is widely regarded as a pore-blocking agent that acts at the cytoplasmic end of the channel. However, there are also data to suggest that there may be an additional, secondary binding site for picrotoxin. Through homology modeling, molecular docking, and molecular dynamics simulations, we show that binding of picrotoxin to this interface pocket correlates with these data, and negative modulation occurs at the pocket via a kinking of the pore-lining helices into a more closed orientation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24028067     DOI: 10.1021/tx400167b

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  8 in total

1.  Pharmacological characterization of the neurotrophic sesquiterpene jiadifenolide reveals a non-convulsant signature and potential for progression in neurodegenerative disease studies.

Authors:  Jeffrey M Witkin; Ryan A Shenvi; Xia Li; Scott D Gleason; Julie Weiss; Denise Morrow; John T Catow; Mark Wakulchik; Masaki Ohtawa; Hai-Hua Lu; Michael D Martinez; Jeffrey M Schkeryantz; Timothy S Carpenter; Felice C Lightstone; Rok Cerne
Journal:  Biochem Pharmacol       Date:  2018-06-22       Impact factor: 5.858

2.  Computational Models for Predictive Cardiac Ion Channel Pharmacology.

Authors:  Vladimir Yarov-Yarovoy; Toby W Allen; Colleen E Clancy
Journal:  Drug Discov Today Dis Models       Date:  2014-08-05

Review 3.  Multiscale Modeling in the Clinic: Drug Design and Development.

Authors:  Colleen E Clancy; Gary An; William R Cannon; Yaling Liu; Elebeoba E May; Peter Ortoleva; Aleksander S Popel; James P Sluka; Jing Su; Paolo Vicini; Xiaobo Zhou; David M Eckmann
Journal:  Ann Biomed Eng       Date:  2016-02-17       Impact factor: 3.934

4.  The neural γ2α1β2α1β2 gamma amino butyric acid ion channel receptor: structural analysis of the effects of the ivermectin molecule and disulfide bridges.

Authors:  Meral Ayan; Sebnem Essiz
Journal:  J Mol Model       Date:  2018-07-14       Impact factor: 1.810

5.  GABAA receptor target of tetramethylenedisulfotetramine.

Authors:  Chunqing Zhao; Sung Hee Hwang; Bruce A Buchholz; Timothy S Carpenter; Felice C Lightstone; Felice Lightstone; Jun Yang; Bruce D Hammock; John E Casida
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-27       Impact factor: 11.205

6.  Phenylalanine in the pore of the Erwinia ligand-gated ion channel modulates picrotoxinin potency but not receptor function.

Authors:  Andrew J Thompson; Mona Alqazzaz; Kerry L Price; David A Weston; Sarah C R Lummis
Journal:  Biochemistry       Date:  2014-09-19       Impact factor: 3.162

7.  The fungal alkaloid Okaramine-B activates an L-glutamate-gated chloride channel from Ixodes scapularis, a tick vector of Lyme disease.

Authors:  Shogo Furutani; Makoto Ihara; Kristin Lees; Steven D Buckingham; Frederick A Partridge; Jonathan A David; Rohit Patel; Scott Warchal; Ian R Mellor; Kazuhiko Matsuda; David B Sattelle
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-06-04       Impact factor: 4.077

8.  An Electrostatic Funnel in the GABA-Binding Pathway.

Authors:  Timothy S Carpenter; Felice C Lightstone
Journal:  PLoS Comput Biol       Date:  2016-04-27       Impact factor: 4.475

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.